BM

Blind Man Capital, LLC

Long-term holder

Total reported value

Reporting period: 2026-03-31 · Number of holdings: 1

Blind Man Capital, LLC disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of — and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
0
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity

Recent moves

  • Unchanged 000000000

     $0.0

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1Ikena Oncology INCStock-Other

Holding changes this quarter

Position changes disclosed by Blind Man Capital, LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1Ikena Oncology INCUnchanged

FAQ

What is Blind Man Capital, LLC and what type of investor is it?
Blind Man Capital, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Blind Man Capital, LLC's largest equity positions?
Based on the latest 13F filing, Blind Man Capital, LLC's top holdings by market value are: 1. Ikena Oncology INC — $0.0
What changes did Blind Man Capital, LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Blind Man Capital, LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Blind Man Capital, LLC focus on?
Sector breakdown data is not yet available for Blind Man Capital, LLC. Check back after the next 13F processing cycle.